☆ 4.1 Editorial Material

Generic drug crisis in Japan and changes leading to the collapse of universal health insurance established in 1961: the case of Kobayashi Kako Co. Ltd.

COST EFFECTIVENESS AND RESOURCE ALLOCATION (2023)

Related references

Note: Only part of the references are listed.

Review Economics

Asian innovation in pharmaceutical and medical device industry - beyond tomorrow

Mihajlo Jakovljevic et al.

Summary: The Asian region has become the second largest biotech market globally, with China and Japan leading in pharmaceuticals and medical devices. There is a growing demand for novel medicines and technologies in Asian societies, with multinational companies from wealthier countries meeting these needs. Domestic manufacturing industries in middle-income countries also play a crucial role. Optimism in terms of domestic GDP growth and biotech industry forecasts remains strong in the years to come.

JOURNAL OF MEDICAL ECONOMICS (2021)

Add to Collection

Article Health Care Sciences & Services

Predictors of (in)efficiencies of Healthcare Expenditure Among the Leading Asian Economies - Comparison of OECD and Non-OECD Nations

Mihajlo Jakovljevic et al.

RISK MANAGEMENT AND HEALTHCARE POLICY (2020)

Add to Collection

Article Oncology

Generic drugs: are they the future for affordable medicine?

The Lancet Oncology

LANCET ONCOLOGY (2018)

Add to Collection

Review Health Care Sciences & Services

Contemporary generic market in Japan - key conditions to successful evolution

Mihajlo B. Jakovljevic et al.

EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2014)

Add to Collection

Article Business

Crisis and change in the system of innovation: The Japanese pharmaceutical industry during the Lost Decades, 1990-2010

Maki Umemura

BUSINESS HISTORY (2014)

Add to Collection

Article Health Care Sciences & Services

Drug Shortages After the Eastern Japan Earthquake: Experiences in a Tertiary Referral Center

Jinichi Mori et al.

DRUG INFORMATION JOURNAL (2012)

Add to Collection

Article Medicine, General & Internal

Japan: Universal Health Care at 50 years 3 Cost containment and quality of care in Japan: is there a trade-off?

Hideki Hashimoto et al.

LANCET (2011)

Add to Collection

Article Health Policy & Services

The generic drug market in Japan: will it finally take off?

Toshiaki Iizuka et al.

HEALTH ECONOMICS POLICY AND LAW (2011)

Add to Collection

© Peeref 2019-2024. All rights reserved.